Sources: Global Glucagon-like Peptide 1 (GLP-1) Market Analysis Report 2023: Potential Clinical Application of GLP-1 Receptor Agonists For the Treatment of NASH Gaining Momentum. GlobeNewswire, January 30, 2023
MacroFactor is a strong adaptive macro tracker and nutrition coach for people who want calorie and macro targets, fast food logging, detailed nutrient tracking, expenditure estimates, and bodyweight trend analytics
Frontiers in Pharmacology, 16 , 1572197
Did you just start the medication
Citing limitations in the study, Novo Nordisk, which makes the drugs included in the claims analysis, said in a statement reported by Reuters that it does not believe these data are sufficient to draw conclusions about overall patient adherence and persistence to various GLP-1 medicines, including our treatments. Nonetheless, the problem of lack of patient persistence on GLP-1s under real-world conditions, examined and published by a growing number of sources, isnt going away
When the medication is removed, that system gradually reasserts itself
